凱倫股份(300715.SZ):擬與棋盤農業科技設合資公司 共同開發屋頂分佈式光伏發電項目
格隆匯2月25日丨凱倫股份(300715.SZ)公佈,為拓展高分子防水材料在屋頂分佈式光伏領域的應用,進一步鞏固公司高分子市場競爭地位,更好地實施業務發展戰略,公司擬與吉林棋盤農業科技股份有限公司(“棋盤農業科技”)共同投資設立合資公司,合資公司註冊資本為人民幣1000萬元,其中公司擬佔股70%,棋盤農業科技擬佔股30%。合資公司將充分利用凱倫股份在“全生命週期光伏屋頂”(CSPV)系統的競爭優勢,以及棋盤農業科技在新能源與鄉村振興方面的豐富經驗,共同開發屋頂分佈式光伏發電項目。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.